We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

303 hedge funds and large institutions have $4.08B invested in United Therapeutics in 2020 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 94 increasing their positions, 100 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more funds holding in top 10

Funds holding in top 10: 7 → 13 (+6)

64% more call options, than puts

Call options by funds: $24.1M | Put options by funds: $14.6M

12% more capital invested

Capital invested by funds: $3.63B → $4.08B (+$453M)

4.16% more ownership

Funds ownership: 93.94% → 98.11% (+4.2%)

6% less repeat investments, than reductions

Existing positions increased: 94 | Existing positions reduced: 100

5% less funds holding

Funds holding: 320 → 303 (-17)

21% less first-time investments, than exits

New positions opened: 50 | Existing positions closed: 63

Holders
303
Holders Change
-17
Holders Change %
-5.31%
% of All Funds
6.68%
Holding in Top 10
13
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+85.71%
% of All Funds
0.29%
New
50
Increased
94
Reduced
100
Closed
63
Calls
$24.1M
Puts
$14.6M
Net Calls
+$9.44M
Net Calls Change
+$8.39M

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$55M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$51M
3
CCM
Consonance Capital Management
New York
+$41M
4
FCM
Farallon Capital Management
California
+$34.7M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$26.4M

Top Sellers

Rank Fund Capital Flow
1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$48.8M
2
PAI
Palo Alto Investors
California
-$39.2M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$34.7M
4
Millennium Management
Millennium Management
New York
-$25M
5
TSW
Thompson Siegel & Walmsley
Virginia
-$21.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
276
EPG Wealth Management
Georgia
$4K – – –
SSB
277
Sandy Spring Bank
Maryland
$4K – – –
SWM
278
Sugarloaf Wealth Management
Georgia
$4K – – –
Group One Trading
279
Group One Trading
Illinois
$3K -$190K -2,000 -99%
HIA
280
Harbor Investment Advisory
Maryland
$3K – – –
TCM
281
Tradewinds Capital Management
Washington
$3K +$3.04K +32 New
WQ
282
Wealth Quarterback
New Jersey
$2.75K – – –
GWS
283
Glassman Wealth Services
Virginia
$2K – – –
GT
284
Glenmede Trust
Pennsylvania
$2K – – –
EI
285
Ellevest Inc
New York
$2K +$760 +8 +57%
NICM
286
Neo Ivy Capital Management
New York
$2K +$1.52K +16 New
GC
287
Globeflex Capital
California
$2K +$2.19K +23 New
ABC
288
Associated Banc-Corp
Wisconsin
$2K +$2.38K +25 New
TPCW
289
TD Private Client Wealth
New York
$1.42K – – –
AAM
290
Advisors Asset Management
Colorado
$1K – – –
EARNEST Partners
291
EARNEST Partners
Georgia
$1K – – –
IA
292
IFP Advisors
Florida
$1K – – –
OAM
293
Oppenheimer Asset Management
New York
$1K – – –
VFA
294
Valeo Financial Advisors
Indiana
$1K +$570 +6 New
EFSCE
295
Enterprise Financial Services Corp (EFSC)
Missouri
$1K +$950 +10 New
AIC
296
Ameritas Investment Company
Nebraska
$1K +$1.24K +13 New
SQA
297
Simon Quick Advisors
New Jersey
$1K +$1.24K +13 New
DWM
298
Darwin Wealth Management
Florida
$1K +$1.52K +16 New
OAM
299
Optimal Asset Management
California
$930 +$180K +1,892 +24%
Arrowstreet Capital
300
Arrowstreet Capital
Massachusetts
– -$48.8M -554,264 Closed
10 11
12
13 14

UTHR Hedge Fund Activity: Q1 2020 in Review

303 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q1 2020, worth a combined $4.08B — up 12% from $3.63B a quarter earlier.

Sellers outnumbered buyers: 63 funds closed out of UTHR and 50 opened new positions — a net loss of 13 holders — while 100 trimmed existing stakes and 94 added.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $55M. The largest seller was Arrowstreet Capital, exiting entirely with an estimated $48.8M sold.

  • 303 institutional investors held United Therapeutics (UTHR) as of Q1 2020, down from 320 in Q4 2019.
  • Funds reported $4.08B of United Therapeutics stock for Q1 2020, up 12% quarter-over-quarter.
  • 50 funds opened new United Therapeutics positions in Q1 2020 and 63 closed out, a net change of -13 holders.
  • The largest United Therapeutics buyer in Q1 2020 was Point72 Asset Management, an estimated $55M added.
  • The largest United Therapeutics seller in Q1 2020 was Arrowstreet Capital, an estimated $48.8M sold.

Based on aggregated 13F filings for Q1 2020.